GLP-1 medications in Phenotype C phenotypes reduce disease endpoints, but this is not the same thing as saying everyone should be on them, and it's not the same thing as saying they're anti-aging; it means in specific phenotypes, they reduce disease momentum.

normativepending

Speaker

Dr. Amin Dadgar

Evidence Quote

“That's not the same thing as saying everyone should be on them. And it's not the same thing as saying they're anti-aging. It means in specific phenotypes, they reduce disease momentum.”

Source

Ozempic & Mounjaro: Same Shot. Opposite Results.— Dr. Amin Hedayat, MD
Created: 8/12/2026, 6:40:36 PM

Your notes

Loading notes...